Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

83 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q4 2021.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 52.5M shares of 266M outstanding shares and own 19.71% of the company stock.
Largest 10 shareholders include Blackstone Inc (18M shares), Syncona Portfolio Ltd (7.35M shares), Nantahala Capital Management, LLC (4.08M shares), FRAZIER MANAGEMENT LLC (3.75M shares), Capital World Investors (2.96M shares), Polygon Management Ltd. (2.7M shares), CITADEL ADVISORS LLC (1.7M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.67M shares), FMR LLC (1.64M shares), and Pendal Group Ltd (1.44M shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.